HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Uterine sarcomas in CBA mice induced by combined treatment with 1,2-dimethylhydrazine and estradiol dipropionate. Light and electron microscopy.

Abstract
Three uterine sarcomas induced by combined treatment (1,2-dimethylhydrazine and estradiol dipropionate) in CBA mice were examined by light and electron microscopy. Histologically the tumours consisted either of loose areas with stellate cells or of solid cellular areas. These were formed of elongated cells of the fibroblastic type and rounded cells with clear nuclei and abundant cytoplasm without clearly discernible bodies. Ultrastructurally, undifferentiated mesenchymal cells and cells with the features of fibroblasts and myofibroblasts were distinguished. The tumours described bear resemblance to human endometrial stromal sarcomas and are interpreted as sarcomas originating from immature mesenchymal cells differentiating mainly in the direction of cells of the fibroblastic type. Certain similarities with fibrous histiocytomas are noted.
AuthorsV S Turusov, N T Raikhlin, E A Smirnova, L S Trukhanova
JournalExperimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie (Exp Toxicol Pathol) Vol. 45 Issue 2-3 Pg. 161-6 (May 1993) ISSN: 0940-2993 [Print] Germany
PMID8329867 (Publication Type: Journal Article)
Chemical References
  • Carcinogens
  • Dimethylhydrazines
  • Estradiol
  • 1,2-Dimethylhydrazine
  • estradiol dipropionate
Topics
  • 1,2-Dimethylhydrazine
  • Animals
  • Carcinogens
  • Dimethylhydrazines
  • Estradiol (analogs & derivatives)
  • Female
  • Mice
  • Mice, Inbred CBA
  • Microscopy, Electron
  • Sarcoma, Experimental (chemically induced, pathology, ultrastructure)
  • Uterine Neoplasms (chemically induced, pathology, ultrastructure)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: